Omeros (OMER) Operating Margin (2010 - 2026)

Omeros' (OMER) quarterly Operating Margin came in at 176.09% in Q1 2026, down 32.66% quarter-over-quarter from 132.74% in Q3 2021.

Omeros (OMER) Operating Margin (2010 - 2026) Analysis & Trends

Omeros has disclosed Operating Margin across 13 years of filings, most recently posting 176.09% for Q1 2026.

Operating Margin for Q1 2026 came in at 176.09%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 153.15% (up 5074.0% YoY), and the FY2020 annual result was 212.59%, down 8197.0% from the prior year.
Operating Margin came in at 176.09% for Q1 2026 at Omeros, down from 132.74% in the prior quarter.
In the past five years, Operating Margin ranged from a high of 176.09% in Q1 2026 to a low of 176.09% in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Operating Margin (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-6.43%
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	38.10%
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Omeros	737.87 Mn	602.55 Mn	9.31 Mn	-176.09%

Download Data